Patients were knowledgeable about goals and outcomes of maintenance therapy for non-small cell lung cancer (NSCLC).

Decision-making regarding treatment of NSCLC is a shared process between patients and physicians; physicians were the main source of information about therapy options and were almost always strongly involved in the decision-making process.

A main motivator for patients to accept therapy is the potential to extend survival.

A major challenge to receiving therapy is the possibility of adverse effects.

Discussions between patients and physicians on goals of therapy and management of possible adverse effects play an important role in patients’ decision to receive therapy.